CTBP1 and neoplasm: As CtBP oligomerization is a critical mechanistic link between chemical inhibition and functional inactivation, we envision that a tumor cell CtBP dimerization assay could serve as a companion pharmacodynamic biomarker to the dual NAMPT/CtBP inhibition therapeutic strategy.